Quality Control of Involved Field Radiotherapy in Patients With Early-Favorable (HD10) and Early-Unfavorable (HD11) Hodgkin's Lymphoma: An Analysis of the German Hodgkin Study Group

Involved Field ◽

Comparison of 30 Gy versus 20 Gy Involved Field Radiotherapy After Two Versus Four Cycles ABVD in Early Stage Hodgkin’s Lymphoma: Interim Analysis of the German Hodgkin Study Group Trial HD10

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2005.07.008 ◽

2005 ◽

Vol 63 ◽

pp. S1-S2 ◽

Cited By ~ 12

Author(s):

H. Eich ◽

R. Mueller ◽

A. Engert ◽

K. Hansemann ◽

R. Skripnitchenko ◽

...

Keyword(s):

Interim Analysis ◽

Hodgkin’S Lymphoma ◽

Early Stage ◽

Hodgkin's Lymphoma ◽

Study Group ◽

Involved Field ◽

Involved Field Radiotherapy ◽

Group Trial

Biophysical analysis of the acute toxicity of radiotherapy in Hodgkin’s lymphoma—a comparison between extended field and involved field radiotherapy based on the data of the German Hodgkin Study Group

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2005.02.053 ◽

2005 ◽

Vol 63 (3) ◽

pp. 860-865 ◽

Cited By ~ 14

Author(s):

Hans Theodor Eich ◽

Uwe Haverkamp ◽

Andreas Engert ◽

Martin Kocher ◽

Roman Skripnitchenko ◽

...

Keyword(s):

Acute Toxicity ◽

Hodgkin’S Lymphoma ◽

Hodgkin's Lymphoma ◽

Study Group ◽

Biophysical Analysis ◽

Extended Field ◽

Involved Field ◽

Quality Control of Involved Field Radiotherapy in Patients With Early-Favorable (HD10) and Early-Unfavorable (HD11) Hodgkin's Lymphoma-An Analysis of the German Hodgkin's Study Group (GHSG)

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2007.07.1774 ◽

2007 ◽

Vol 69 (3) ◽

pp. S535

Author(s):

H.T. Eich ◽

R. Engenhart-Cabillic ◽

K. Hansemann ◽

P. Lukas ◽

H. Seegenschmiedt ◽

...

Keyword(s):

Quality Control ◽

Hodgkin’S Lymphoma ◽

Hodgkin's Lymphoma ◽

Study Group ◽

Involved Field ◽

Biophysical analysis of acute toxicity of radiotherapy in Hodgkin’s lymphoma — a comparison between extended field and involved field radiotherapy based on the data of the german hodgkin study group (GHSG)

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/s0360-3016(04)01229-5 ◽

2004 ◽

Vol 60 ◽

pp. S219-S219

Author(s):

H EICH ◽

U HAVERKAMP ◽

A ENGERT ◽

M KOCHER ◽

R SKRIPNITCHENKO ◽

...

Keyword(s):

Acute Toxicity ◽

Hodgkin’S Lymphoma ◽

Hodgkin's Lymphoma ◽

Study Group ◽

Biophysical Analysis ◽

Extended Field ◽

Involved Field ◽

Poorer outcome of elderly patients treated with extended-field radiotherapy compared with involved-field radiotherapy after chemotherapy for Hodgkin's lymphoma: an analysis from the German Hodgkin Study Group

Annals of Oncology ◽

10.1093/annonc/mdl379 ◽

2007 ◽

Vol 18 (2) ◽

pp. 357-363 ◽

Cited By ~ 45

Author(s):

B. Klimm ◽

H.T. Eich ◽

H. Haverkamp ◽

A. Lohri ◽

P. Koch ◽

...

Keyword(s):

Elderly Patients ◽

Hodgkin’S Lymphoma ◽

Hodgkin's Lymphoma ◽

Study Group ◽

Extended Field ◽

Involved Field ◽

Biophysical analysis of acute toxicity of radiotherapy in Hodgkin’s lymphoma — a comparison between extended field and involved field radiotherapy based on the data of the german hodgkin study group (GHSG)

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2004.06.172 ◽

2004 ◽

Vol 60 (1) ◽

pp. S219

Author(s):

H. Eich ◽

U. Haverkamp ◽

A. Engert ◽

M. Kocher ◽

R. Skripnitchenko ◽

...

Keyword(s):

Acute Toxicity ◽

Hodgkin’S Lymphoma ◽

Hodgkin's Lymphoma ◽

Study Group ◽

Biophysical Analysis ◽

Extended Field ◽

Involved Field ◽

Extended field radiotherapy, combined modality treatment or involved field radiotherapy for patients with stage IA lymphocyte-predominant Hodgkin's lymphoma: a retrospective analysis from the German Hodgkin Study Group (GHSG)

Annals of Oncology ◽

10.1093/annonc/mdi323 ◽

2005 ◽

Vol 16 (10) ◽

pp. 1683-1687 ◽

Cited By ~ 105

Author(s):

L. Nogová ◽

T. Reineke ◽

H.T. Eich ◽

A. Josting ◽

H.K. Müller-Hermelink ◽

...

Keyword(s):

Retrospective Analysis ◽

Hodgkin's Lymphoma ◽

Combined Modality Treatment ◽

Study Group ◽

Combined Modality ◽

Stage Ia ◽

Extended Field ◽

Involved Field ◽

461 oral Quality control of involved-field radiotherapy in patients with advanced stage Hodgkin's lymphoma (HL) enrolled on the EORTC trial 20884

Radiotherapy and Oncology ◽

10.1016/s0167-8140(04)82328-4 ◽

2004 ◽

Vol 73 ◽

pp. S205-S206

Keyword(s):

Quality Control ◽

Hodgkin’S Lymphoma ◽

Hodgkin's Lymphoma ◽

Advanced Stage ◽

Involved Field ◽

Quality control of involved-field radiotherapy in patients with advanced Hodgkin’s lymphoma (EORTC 20884)

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2005.03.044 ◽

2005 ◽

Vol 63 (4) ◽

pp. 1184-1190 ◽

Cited By ~ 17

Author(s):

Berthe M.P. Aleman ◽

Théodore Girinsky ◽

Richard W.M. van der Maazen ◽

Simon Strijk ◽

Paul Meijnders ◽

...

Keyword(s):

Quality Control ◽

Hodgkin’S Lymphoma ◽

Hodgkin's Lymphoma ◽

Involved Field ◽

Advanced Hodgkin’S Lymphoma ◽

460 oral Comparison of 30 Gy versus 20 Gy involved field radiotherapy after two versus four cycles ABVD in early stage Hodgkin's disease: interim results of the German Hodgkin's Lymphoma Study Group (GHSG) trial hd10

Radiotherapy and Oncology ◽

10.1016/s0167-8140(04)82327-2 ◽

2004 ◽

Vol 73 ◽

pp. S205

Keyword(s):

Hodgkin's Disease ◽

Hodgkin’S Lymphoma ◽

Early Stage ◽

Hodgkin’S Disease ◽

Hodgkin's Lymphoma ◽

Study Group ◽

Lymphoma Study Group ◽

Involved Field ◽